Oncology and Translational Medicine
Wolters Kluwer Health - Lippincott Williams Wilkins
About the journal
Oncology and Translational Medicine is an open-access journal published by Wolters Kluwer Health - Lippincott Williams Wilkins in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wolters Kluwer Health - Lippincott Williams Wilkins
- ISSN
- 2095-9621 · 2995-5858
- Country
- United States
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 8
- Declared review time
- 24 weeks
- Declared peer-review model
- double_blind
- Official website
- https://journals.lww.com/otm/pages/default.aspx
Index listings
- DOAJ · 2024-07-23
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 24 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
8
Most recent article
11 months ago
Average review time (journal-declared via DOAJ)
24weeks
Works in OpenAlex
549
Last recorded publication year
2026
h-index
10
i10-index
11
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2024-07-23
- Added to DOAJ
- 2024-07-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 18%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
Show all subjects (50)
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- RNA modifications and cancer
- RNA modifications and cancer
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- MicroRNA in disease regulation
- Colorectal Cancer Treatments and Studies
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Colorectal Cancer Treatments and Studies
- MicroRNA in disease regulation
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Advanced Radiotherapy Techniques
- Advanced Radiotherapy Techniques
- Immunotherapy and Immune Responses
- Circular RNAs in diseases
- Cancer, Hypoxia, and Metabolism
- Immunotherapy and Immune Responses
- Circular RNAs in diseases
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Cancer Cells and Metastasis
- Renal cell carcinoma treatment
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Renal cell carcinoma treatment
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Cancer, Lipids, and Metabolism
- Immune Cell Function and Interaction
- Cancer, Lipids, and Metabolism
- Ovarian cancer diagnosis and treatment
- Immune Cell Function and Interaction
- Ovarian cancer diagnosis and treatment
Keywords (DOAJ)
- oncology
- translational medicine
- immunology
- chemotherapy
- radiotherapy
- diagnosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ